Kathleen A. Rickard, Chief Medical Officer at Verona Pharma plc (VRNA), sold 130,744 shares at $2.50 ($331K) on 2023-08-04, disclosed to the SEC on 2023-08-07.
Scheduled sale ($331k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.54 | 21,848 | $55K | 16.7% |
| 2 | $2.54 | 21,848 | $55K | 16.7% |
| 3 | $2.55 | 28,752 | $73K | 22.1% |
| 4 | $2.55 | 28,752 | $73K | 22.1% |
| 5 | $2.50 | 27,944 | $70K | 21.1% |
| 6 | $2.47 | 1,600 |
| $4K |
| 1.2% |
| Total | $2.53 avg | 130,744 | $331K | 100% |
| Filing → |
| VRNA | SELL | 2025-05-05 | $881K | — | Filing → |
| VRNA | SELL | 2025-05-01 | $618K | — | Filing → |
| VRNA | SELL | 2025-03-13 | $1.3M | — | Filing → |